drugset
drugset / Trial / NCT04304157

Median Effective Dose of Dexmedetomidine in Elective Upper Limb Lidocaine Intravenous Regional Anesthesia

NCT04304157 ↗

Phase 4 Completed 81 enrolled South Valley University Tanta University · collab
RandomizedSequentialQuadruple-blindTreatment

Summary

Auxiliary drugs augment the effect of local anesthetic in intravenous regional anesthesia (IVRA). The purpose of our study was to estimate the median effective dose (ED50) of Dexmedetomidine in elective upper limb Lidocaine 0.5% IVRA.

Timeline

Start
2019-08-01
Primary completion
2020-02-29
Completion
2020-03-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.4 ug/kg —

Indications

No indication recorded.